Chronic Lymphocytic Leukemia CLL Product release

Chronic Lymphocytic Leukemia CLL Product release

Molecular Diagnostics

June 03, 2015

Multiplicom is pleased to announce the release of the new CLL MASTR Plus, a RUO assay for identification of mutations in the coding regions of 9 genes related to CLL.

The CLL MASTR Plus is a molecular assay for the identification of both SNVs and CNAs in 9 selected genes (listed under the specifications tab) in individuals with indication of CLL.
Multiplicom’s CLL MASTR Plus assay is provided as a ready-to-use kit that offers robust performance with minimum hands-on time. All reagents for multiplex amplification of 251 unique amplicons (261-437 bp), ensuring complete coverage of all coding sequences in 6 PCR reactions are included.
The assay is compatible with all current Massively Parallel Sequencing (MPS) systems, providing the flexibility to choose your preferred method.

Enrich and detect CTCs of prostate cancer from blood

Enrich and detect CTCs of prostate cancer from blood

Molecular Diagnostics

Circulating tumor cells (CTCs) constitute a useful approach for personalized medicine. In prostate cancer, the expression of three tumor-associated transcripts, prostate-specific membrane antigen (PSMA), prostate-specific antigen (PSA) and epidermal growth factor receptor (EGFR), are often altered and used as biomarkers.

March 01, 2017 More +
Mouse SimpleStep ELISA Kits

Mouse SimpleStep ELISA Kits

Molecular Diagnostics

ELISA kits to mouse targets may be less reproducible, specific and sensitive when compared to ELISA kits to other species’ targets due to the use of batch-specific polyclonal antibodies. Use of monoclonal antibodies in ELISA is preferred for target specificity and reproducibility; however, mouse monoclonal antibodies cannot be generated to mouse targets and the use of related rodent hosts, such as rat are difficult to produce.


June 12, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us